FMS Fresenius Medical Care AG & Co. KGaA logo

FMS Fresenius Medical Care AG & Co. KGaA

Healthcare
$21.64+0.05%ClosedMarket Cap: $11.62B

As of 2026-05-25

Valuation

View Details

P/E (TTM)

13.92

PEG

0.17

P/B

0.78

P/S

0.52

EV/EBITDA

5.74

DCF Value

$91.58

FCF Yield

17.7%

Div Yield

4.0%

Margins & Returns

Gross Margin

26.0%

Operating Margin

10.2%

Net Margin

4.9%

ROE

7.2%

ROA

3.0%

ROIC

5.8%

Financials

View All
PeriodRevenueNet IncomeEPS
Q1 null$4.61B$117.5M$
Q4 null$5.07B$327.1M$
FY null$19.63B$978.4M$
Q3 null$4.88B$274.8M$

Analyst Ratings

View All

Consensus

Hold

Target (Consensus)

$28.00

Target (Median)

$28.00

Target Range

$28.00 - $28.00

0 Strong Buy2 Buy3 Hold1 Sell1 Strong Sell
UBSSell
2025-09-02

Trading Activity

Insider Trades

View All
Renkewitsch Olgaofficer
SellWed Mar 18

Company Info

Sector

Healthcare

Industry

Medical - Care Facilities

Country

DE

Exchange

Beta

0.82

Fresenius Medical Care AG & Co. KGaA provides dialysis care and related dialysis care services in Germany, North America, and internationally. It offers dialysis treatment and related laboratory and diagnostic services through a network of outpatient dialysis clinics; materials, training, and patient support services comprising clinical monitoring, follow-up assistance, and arranging for delivery of the supplies to the patient's residence; and dialysis services under contract to hospitals in the United States for the hospitalized end-stage renal disease (ESRD) patients and for patients suffering from acute kidney failure. The company also develops, manufactures, and distributes dialysis products, including polysulfone dialyzers, hemodialysis machines, peritoneal dialysis cyclers, peritoneal dialysis solutions, hemodialysis concentrates, solutions and granulates, bloodlines, renal pharmaceuticals, and systems for water treatment; and non-dialysis products, such as acute cardiopulmonary and apheresis products. In addition, it develops, acquires, and in-licenses renal pharmaceuticals; offers renal medications and supplies to patients at homes or to dialysis clinics; and provides vascular, cardiovascular, endovascular specialty, vascular care ambulatory surgery center, and physician nephrology and cardiology services. The company sells its products to dialysis clinics, hospitals, and specialized treatment clinics directly, as well as through local sales forces, independent distributors, dealers, and sales agents. As of February 23, 2022, it operated 4,171 outpatient dialysis clinics in approximately 150 countries. Fresenius Medical Care AG & Co. KGaA was incorporated in 1996 and is headquartered in Bad Homburg, Germany.

Peers